Deadline for application
Suitable candidates must be determined, proactive, independent, eager to learn and with strong working capacity who have a PhD in biological/medical sciences and good scientific productivity proven by good scientific publications. Technical/scientific requirements include:
Strong experience in immunology assays and cell biology.
Proficiency in flow cytometry.
Experience in handling primary blood samples.
Experience with mouse models (ideally immunodeficient xenografts).
Excellent interpersonal skills and the ability to work with other team members and external national and international collaborators.
Good oral and written communications skills.
Previous experience in MSC biology and RNAseq is a must.
The Josep Carreras Leukemia Research Institute (IJC) is a nonprofit research institute based in Barcelona and dedicated to advancing our understanding about leukemia and related disorders, in partnership with the University of Barcelona and University Autónoma of Barcelona. The IJC has laboratories in three clinical campuses: i) Clinic Hospital, ii) Sant Pau Hospital and iii) Germans Trias i Pujol Hospital. IJC serves as a collaborative hub for basic investigators and physicians to work together on fundamental biological and clinical aspects of leukemia. The IJC offers an excellent work environment built around a multi-disciplinary fusion of ideas and state-of-the-art facilities. For additional information please visit: www.carrerasresearch.org
Pablo Menendez´s Laboratory, located in the Campus Clinic/School of Medicine of the University of Barcelona, is an ERC-funded young, dynamic and growing research team working on the frontiers of leukemia research, immunotherapy and stem cell biology. We are looking for a researcher to participate in a project funded by the European Commission (ERC- CLOSER – 825749) and Health Canada aimed to advance the biology and clinical application of human mesenchymal stem cells (MSC) derived from healthy bone marrow (BM) and from diseased BM from patients with active acute leukemia. We anticipate to optimize scRNASeq methods and inducible systems to resolve MSC heterogeneity and study their immunosuppressive and anti-inflammatory properties in vitro and in vivo using suitable mouse models for autoimmune diseases and adoptive cell immunotherapy (CAR T cells).
- Conduct cellular, molecular, biochemical, and immunology in vitro experiments.
- Design, develop and conduct in vivo experiments with BM-MSC cells using mouse models for autoimmune diseases and adoptive cell immunotherapy.
- Conduct data analysis and prepare data for presentation in peer-reviewed journals, grant preparation and professional meetings.
What we offer:
To work in an excellent environment in the stunning city of Barcelona.
An initial 2-year research contract with possible renewal up to 5 years based on performance and commitment.
Starting date before 1st April 2019.
A salary commensurate to research qualifications and innovative potential.
For more information:
Place of presentation of the candidacies
How to Apply:
Interested applicants should send their CV (containing the contact details of two referees) and a motivation letter: email@example.com
PLEASE PUT THE REFERENCE in the subject of the mail or your application may not reach the right person.
Deadline for applications: 20/02/2019